Annexure attached as per the subject.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kothari Fermentation & Biochem Ltd reported a net loss of Rs. 420.18 lakhs for H1 FY26 (ended September 30, 2025), sharply higher than the loss of Rs. 65.23 lakhs in H1 FY25. Revenue from operations fell about 7.4% year-on-year to Rs. 4,771.42 lakhs from Rs. 5,152.20 lakhs. In Q2 FY26 alone, the company posted a loss of Rs. 307.72 lakhs (vs Rs. 175 lakhs loss in Q2 FY25), with EBITDA margins compressing sharply due to higher depreciation and finance costs. The statutory auditor issued an unqualified review report but included an Emphasis of Matter drawing attention to overdue statutory dues of about Rs. 14.68 lakhs (TDS and PF) pending for over six months. Despite losses, operating cash flow remained positive at Rs. 420.01 lakhs in H1 FY26.
Widening losses, revenue decline, and margin compression are clearly negative for the stock and shareholders, especially after the company reported a small profit of Rs. 60.99 lakhs in full-year FY25. The overdue statutory dues flagged by auditors are a minor compliance red flag, but the overall audit opinion remains clean, and positive operating cash flow offers some comfort on short-term liquidity.